Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 3/20 | 0.54 |
| ▸ | LY96 | Q9Y6Y9 | 1/20 | 0.44 |
| ▸ | BCHE | P06276 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | IKBKB | O14920 | 1/20 | 0.38 |
| ▸ | DYRK2 | Q92630 | 1/20 | 0.38 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.38 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.38 |
| ▸ | FGFR3 | P22607 | 1/20 | 0.38 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 2/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | RELA | Q04206 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9812208 | 1.00 | HSD11B1 (0.54) | HSD11B1LY96BCHEALDH1A1KMT2A | |
| SCHEMBL2582420 | 1.00 | HSD11B1 (0.54) | HSD11B1LY96BCHEALDH1A1KMT2A | |
| SCHEMBL8900317 | 0.84 | HSD11B1 (0.62) | HSD11B1LY96BCHEALDH1A1KMT2A | |
| SCHEMBL1751871 | 0.84 | HSD11B1 (0.62) | HSD11B1LY96BCHEALDH1A1KMT2A | |
| SCHEMBL297691 | 0.84 | HSD11B1 (0.62) | HSD11B1LY96BCHEALDH1A1KMT2A | |
| SCHEMBL31613215 | 0.84 | HSD11B1 (0.62) | HSD11B1LY96BCHEALDH1A1KMT2A | |
| SCHEMBL4214812 | 0.81 | ALDH1A1 (0.37) | HSD11B1LY96ALDH1A1KMT2AMEN1 | |
| SCHEMBL12913343 | 0.81 | ALDH1A1 (0.37) | HSD11B1LY96ALDH1A1KMT2AMEN1 | |
| SCHEMBL21786281 | 0.81 | ALDH1A1 (0.37) | HSD11B1LY96ALDH1A1KMT2AMEN1 | |
| SCHEMBL333121 | 0.81 | NFE2L2 (0.41) | ALDH1A1KMT2AMEN1ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118930392-A | Aldehyde deoxidization and reduction method | 温州医科大学 | 2024-11-12 | — | — | CN | disclosed |
| US-9382279-B2 | Copper catalyzed halogenaton and reaction products | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2016-07-05 | — | — | US | disclosed |
| US-9382279-B2 | Copper catalyzed halogenaton and reaction products | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2016-07-05 | — | — | US | disclosed |
| US-9382279-B2 | Copper catalyzed halogenaton and reaction products | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2016-07-05 | — | — | US | disclosed |
| US-20140371480-A1 | COPPER CATALYZED HALOGENATON AND REACTION PRODUCTS | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2014-12-18 | — | — | US | disclosed |
| US-20140371480-A1 | COPPER CATALYZED HALOGENATON AND REACTION PRODUCTS | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2014-12-18 | — | — | US | disclosed |
| US-20140371480-A1 | COPPER CATALYZED HALOGENATON AND REACTION PRODUCTS | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2014-12-18 | — | — | US | disclosed |
| US-8629126-B2 | Quinolone derivative or pharmaceutically acceptable salt thereof | ASTELLAS PHARMA INC. (JP) | 2014-01-14 | — | — | US | disclosed |
| US-8629126-B2 | Quinolone derivative or pharmaceutically acceptable salt thereof | ASTELLAS PHARMA INC. (JP) | 2014-01-14 | — | — | US | disclosed |
| US-20120136025-A1 | QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | ASTELLAS PHARMA INC. (JP) | 2012-05-31 | — | — | US | disclosed |
| US-20090197834-A1 | QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | ASTELLAS PHARMA INC. (JP) | 2009-08-06 | — | — | US | disclosed |
| US-7528167-B2 | Inhibitors of papilloma virus | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2009-05-05 | — | — | US | disclosed |
| EP-1995240-A1 | QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | Astellas Pharma Inc. (JP) | 2008-11-26 | — | — | EP | disclosed |
| US-7173033-B2 | Nitrogen-containing heterocyclic compound | ASTELLAS PHARMA INC. (JP) | 2007-02-06 | — | — | US | disclosed |
| US-7173033-B2 | Nitrogen-containing heterocyclic compound | ASTELLAS PHARMA INC. (JP) | 2007-02-06 | — | — | US | disclosed |
| US-6492392-B1 | INHIBITING TUMOR CELL PROLIFERATION | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2002-12-10 | — | — | US | disclosed |
| WO-2001085716-A1 | 2-PIPERIDONE COMPOUNDS FOR THE TREATMENT OF CANCER | KYOWA HAKKO KOGYO CO., LTD (JP) | 2001-11-15 | — | — | WO | disclosed |
| EP-0350069-B1 | METHOD FOR OXIDIZING UNSATURATED AROMATIC COMPOUNDS | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1993-03-17 | — | — | EP | disclosed |
| US-4967009-A | REACTING UNSATURATED AROMATIC COMPOUNDS WITH AROMATIC IODOSYL COMPOUNDS TO YIELD AROMATIC ALDEHYDES OR KETONES | NIPPON PETROCHEMICALS CO., LTD. (JP) | 1990-10-30 | — | — | US | disclosed |
| EP-0104863-B1 | LIGHT-SENSITIVE PLANOGRAPHIC PRINTING PLATE | FUJI PHOTO FILM CO., LTD. (JP) | 1989-05-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120136025-A1 | QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | P2RY10, P2RY12, P2RY11 | HSD11B1 1642/4885LY96 1459/4885BCHE 4249/4885 |
| US-20140371480-A1 | COPPER CATALYZED HALOGENATON AND REACTION PRODUCTS | AOC3, AOC2, BAZ2A | HSD11B1 420/4885LY96 4727/4885BCHE 760/4885 |
| US-20090197834-A1 | QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | P2RY12, P2RY11, P2RY10 | HSD11B1 1543/4885LY96 2149/4885BCHE 4314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.